Zurich, Switzerland and Moscow, Russia, 1 April 2021
Acino will supply medicines for children with mental and behavioral disorders, schizophrenia, affective disorders, and hyperkinetic disorders
Acino Belarus won the prize with our #WorldHeartDay campaign, beating 80 participants including pharmaceutical manufacturers, distributors and pharmacy chains from 13 countries in the Eurasia region
This World Heart Day, September 29, and for the next year, Acino will support the World Heart Federation to raise awareness of cardiovascular disease (CVD) as the leading cause of death for patients around the world
Eugene Zaika General Director of Acino in Ukraine and Regional Head of Acino in CIS, told pharma.net.ua that while the company’s ambitious plans have not yet been fully realized, they are still very relevant, especially at the moment.
USD 160,600 donated.
1,200 hospitals and 2,225 pharmacies assisted.
17,000 healthcare professionals and 5,000 pharmacists equipped.
We're in this together.
We are currently all facing a time that we have never experienced before as individuals or as businesses; and are creating and adapting to new ways of living and working.
Acino and Takeda Pharmaceuticals announced today the completion of the acquisition for parts of Takeda’s primary care portfolio in selected countries in the Middle East, Africa, and Ukraine.